Vanguard Group’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.12M Sell
610,337
-7,598
-1% -$114K ﹤0.01% 2954
2025
Q1
$7.24M Buy
617,935
+49,919
+9% +$585K ﹤0.01% 3023
2024
Q4
$13M Sell
568,016
-8,144
-1% -$186K ﹤0.01% 2810
2024
Q3
$24.2M Buy
576,160
+12,635
+2% +$530K ﹤0.01% 2504
2024
Q2
$20.5M Buy
563,525
+56,042
+11% +$2.04M ﹤0.01% 2559
2024
Q1
$25.8M Buy
507,483
+457,062
+906% +$23.3M ﹤0.01% 2469
2023
Q4
$977K Buy
50,421
+36
+0.1% +$698 ﹤0.01% 3834
2023
Q3
$796K Sell
50,385
-156
-0.3% -$2.47K ﹤0.01% 3913
2023
Q2
$839K Sell
50,541
-274
-0.5% -$4.55K ﹤0.01% 3952
2023
Q1
$711K Hold
50,815
﹤0.01% 4015
2022
Q4
$517K Sell
50,815
-479
-0.9% -$4.88K ﹤0.01% 4090
2022
Q3
$657K Sell
51,294
-4,866
-9% -$62.3K ﹤0.01% 4144
2022
Q2
$1.16M Sell
56,160
-7,865
-12% -$162K ﹤0.01% 4038
2022
Q1
$2.41M Sell
64,025
-15,975
-20% -$601K ﹤0.01% 3889
2021
Q4
$7.71M Sell
80,000
-529
-0.7% -$51K ﹤0.01% 3373
2021
Q3
$11.6M Buy
80,529
+850
+1% +$123K ﹤0.01% 3153
2021
Q2
$14.7M Buy
79,679
+3,759
+5% +$694K ﹤0.01% 3004
2021
Q1
$18.7M Buy
75,920
+18,245
+32% +$4.49M ﹤0.01% 2823
2020
Q4
$16.3M Buy
57,675
+3,224
+6% +$909K ﹤0.01% 2739
2020
Q3
$13.1M Buy
54,451
+4,734
+10% +$1.14M ﹤0.01% 2655
2020
Q2
$16.5M Buy
49,717
+23,344
+89% +$7.75M ﹤0.01% 2516
2020
Q1
$6M Buy
26,373
+280
+1% +$63.7K ﹤0.01% 2886
2019
Q4
$6.43M Buy
26,093
+13,823
+113% +$3.41M ﹤0.01% 3078
2019
Q3
$699K Sell
12,270
-4,859
-28% -$277K ﹤0.01% 3742
2019
Q2
$808K Hold
17,129
﹤0.01% 3733
2019
Q1
$924K Hold
17,129
﹤0.01% 3644
2018
Q4
$740K Hold
17,129
﹤0.01% 3646
2018
Q3
$1M Buy
17,129
+484
+3% +$28.4K ﹤0.01% 3720
2018
Q2
$882K Buy
16,645
+854
+5% +$45.3K ﹤0.01% 3722
2018
Q1
$4.45M Buy
15,791
+920
+6% +$259K ﹤0.01% 3199
2017
Q4
$3.5M Buy
14,871
+103
+0.7% +$24.2K ﹤0.01% 3258
2017
Q3
$4.19M Buy
14,768
+644
+5% +$183K ﹤0.01% 3181
2017
Q2
$3.97M Buy
14,124
+873
+7% +$246K ﹤0.01% 3174
2017
Q1
$4.42M Buy
13,251
+571
+5% +$191K ﹤0.01% 3101
2016
Q4
$4.19M Buy
12,680
+2,333
+23% +$770K ﹤0.01% 3130
2016
Q3
$2.76M Buy
10,347
+4,821
+87% +$1.29M ﹤0.01% 3273
2016
Q2
$731K Buy
5,526
+109
+2% +$14.4K ﹤0.01% 3691
2016
Q1
$955K Buy
5,417
+702
+15% +$124K ﹤0.01% 3614
2015
Q4
$1.18M Buy
4,715
+3,133
+198% +$782K ﹤0.01% 3570
2015
Q3
$445K Buy
+1,582
New +$445K ﹤0.01% 3887